4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001562180-19-006260
Chief Business Officer sold 9,867 shares at $16.03 ($158,168)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ISACSON CHRISTINA K. Chief Business Officer | 2019-12-23 | Sale | −9,867 | $16.03 | $158,168 | 88,249 | D |
| Open-market sales · 9,867 sh · avg $16.03 · $158,168 | |||||||
Loading xslF345X03/primarydocument.xml…